BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23414469)

  • 1. Current and evolving knowledge of prognostic factors for pediatric ependymomas.
    Andreiuolo F; Ferreira C; Puget S; Grill J
    Future Oncol; 2013 Feb; 9(2):183-91. PubMed ID: 23414469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric ependymoma: biological perspectives.
    Kilday JP; Rahman R; Dyer S; Ridley L; Lowe J; Coyle B; Grundy R
    Mol Cancer Res; 2009 Jun; 7(6):765-86. PubMed ID: 19531565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
    J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.
    Dyer S; Prebble E; Davison V; Davies P; Ramani P; Ellison D; Grundy R
    Am J Pathol; 2002 Dec; 161(6):2133-41. PubMed ID: 12466129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas.
    Bayliss J; Mukherjee P; Lu C; Jain SU; Chung C; Martinez D; Sabari B; Margol AS; Panwalkar P; Parolia A; Pekmezci M; McEachin RC; Cieslik M; Tamrazi B; Garcia BA; La Rocca G; Santi M; Lewis PW; Hawkins C; Melnick A; David Allis C; Thompson CB; Chinnaiyan AM; Judkins AR; Venneti S
    Sci Transl Med; 2016 Nov; 8(366):366ra161. PubMed ID: 27881822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
    Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared molecular targets in pediatric gliomas and ependymomas.
    Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
    Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
    Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
    Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ependymoma diagnosed in the first year of life in Japan in collaboration with the International Society for Pediatric Neurosurgery.
    Kudo H; Oi S; Tamaki N; Nishida Y; Matsumoto S
    Childs Nerv Syst; 1990 Nov; 6(7):375-8. PubMed ID: 1669244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
    Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
    J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
    J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic and survival factors among pediatric patients with ependymomas].
    López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Gascón-Lastiri G; Ortiz-Suárez L; Rivera-Márquez H; Cerecedo-Díaz F; Wanzke-Del Angel V; De la Cruz-Yáñez H; Ramírez-Reyes G; Arenas-Aranda D; Siordia-Reyes G
    Gac Med Mex; 2009; 145(1):7-13. PubMed ID: 19256405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
    Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
    Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.